Trevena Story

<div class='circular--portrait' style='background:#82ADFD;color: #ffffff;font-size:3em;'>TRV</div>
TRVN -- USA Stock  

USD 1.80  0.02  1.10%

It seems Trevena may not have a good chance to recover from the latest slide as its shares fell again. Trevena current daily volatility is 4.02 percent, with a beta of 1.74 and an alpha of -0.31 over DOW. As many institutional investors getting excited about latest market fluctuations it is important to outline Trevena based on its critical indicators. What exactly are Trevena shareholders getting in April?
Published over a month ago
View all stories for Trevena | View All Stories
Is Trevena (NASDAQ:TRVN) a new disruptor?
Trevena currently holds about 112.68 M in cash with (21.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72.
The entity has a beta of 1.7379, which indicates a somewhat significant risk relative to the market. Let's try to break down what Trevena's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Trevena will likely underperform. Even though it is essential to pay attention to Trevena current price movements, it is always good to be careful when utilizing equity historical returns. Our philosophy towards measuring any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Trevena exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Trevena has an expected return of -0.12%. Please be advised to validate Trevena sortino ratio, as well as the relationship between the semi variance and rate of daily change to decide if Trevena stock performance from the past will be repeated at some point in the near future.
Investing in Trevena, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Trevena along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Trevena's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Trevena in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Trevena. Your research has to be compared to or analyzed against Trevena's peers to derive any actionable benefits. When done correctly, Trevena's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Trevena.

How important is Trevena's Liquidity

Trevena financial leverage refers to using borrowed capital as a funding source to finance Trevena ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Trevena financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Trevena's total debt and its cash.

How Trevena utilizes its cash?

To perform a cash flow analysis of Trevena, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Trevena is receiving and how much cash it distributes out in a given period. The Trevena cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Trevena Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (23.08 Million)

Trevena Correlation with Peers

Investors in Trevena can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Trevena. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Trevena and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Trevena is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Trevena for more details

Acquisition by Johnson Marvin of 118880 shares of Trevena subject to Rule 16b-3

Legal trades by Trevena insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Trevena insider trading alert for grant of stock option (right to buy) by Johnson Marvin, the corporate stakeholder, on 22nd of March 2021. This event was filed by Trevena Inc with SEC on 2021-03-22. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Another angle On Trevena

Trevena owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.029, which indicates the firm had -0.029% of return per unit of risk over the last month. Macroaxis standpoint towards measuring the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Trevena exposes twenty-seven different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Trevena coefficient of variation of (2,746), and Risk Adjusted Performance of (0.021304) to confirm the risk estimate we provide.
NVO
ALXN
VRTX
REGN
BGNE
NVO
0.57-0.30.020.7
NVO
ALXN
0.570.020.10.58
ALXN
VRTX
-0.30.020.65-0.41
VRTX
REGN
0.020.10.650.21
REGN
BGNE
0.70.58-0.410.21
BGNE
NVO
ALXN
VRTX
REGN
BGNE
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Will Trevena slide impact its fundamentals?

Latest Information Ratio is up to -0.06. Price may slide again. Trevena exhibits very low volatility with skewness of 0.65 and kurtosis of 0.95. However, we advise investors to further study Trevena technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Trevena's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Trevena's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Conclusion on Trevena

Whereas some firms in the biotechnology industry are either recovering or due for a correction, Trevena may not be as strong as the others in terms of longer-term growth potentials. In closing, as of the 9th of March 2021, our analysis shows that Trevena actively responds to the market. The company is undervalued and projects very low probability of distress for the next 2 years. Our present 30 days Buy-Hold-Sell recommendation on the company is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Trevena. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com